ebook img

Diabetic Medicine 2003: Vol 20 Index PDF

17 Pages·2003·3.6 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Diabetic Medicine 2003: Vol 20 Index

DIV Indexes Author Index Armstrong, D.G. & Frykberg, R.G. Classifying diabetic foot surgery: toward a rational definition, 329 Abdu, T.A.M. see Barton, D.M. Armstrong, D.G., Dang, C., Nixon, B.P. & Boulton, A.J.M. The Abe, T. see Nagai,Y . hazards of the holiday foot: persons at high risk for diabetic foot Acerini, C.L. see Ford-Adams, M.E. ulceration may be more active on holiday, 247 Adamson, U. see Bragd, J. Arun, C.S., Ngugi, N., Lovelock, L. & Taylor, R. Effectiveness of Adlis, S.A. see Mazze, R.S. screening in preventing blindness due to diabetic retinopathy, Adriaanse, M.C., Snoek, F.J., Dekker, J.M., Spijkerman, A.M.W., 186 Nijpels, G., van der Ploeg, H.M. & Heine, R.J. Perceived risk for Aso, Y., Okumura, K., Yoshida, N., Tayama, K., Kanda, T., Type 2 diabetes in participants in a stepwise population- Kobayashi, I., Takemura, Y. & Inukai, T. Plasma interleukin-6 screening programme, 210 is associated with coagulation in poorly controlled patients with Agrawal, A. & McKibbin, M.A. Technical failure in photographic Type 2 diabetes, 930 screening for diabetic retinopathy, 777 Ahn, C.W. see Kim, D.J. Bachmann, M.O., Eachus, J., Hopper, C.D., Davey Smith, G., Aitken, G. see Sommerfield, A.J. Propper, C., Pearson, N.J., Williams, S., Talion, D. & Frankel, S. Al-Attas, O. see Al-Daghri, N. Socio-economic inequalities in diabetes complications, control, Al-Daghri, N., Al-Rubean, K., Bartlett, W.A., Al-Attas, O., Jones, A.F. attitudes and health service use: a cross-sectional study, 921 & Kumar, S. Serum leptin is elevated in Saudi Arabian patients Baik, S.H. see Choi, K.M. with metabolic syndrome and coronary artery disease, 832 Bain, S.C., Gill, G.V., Dyer, P.H., Jones, A.F., Murphy, M., Jones, K.E., Al-Rubean, K. see Al-Daghri, N. Smyth, C. & Barnett, A.H. Characteristics of Type 1 diabetes of Alazri, M.H. & Neal, R.D. The association between satisfaction over 50 years duration (the Golden Years Cohort), 808 with services provided in primary care and outcomes in Type 2 Baldeweg, S.E. & Rosenthal, M. The 20th Annual Meeting of the diabetes mellitus, 486 Anglo—Danish—Dutch Diabetes Group, 332 Albert, A. see Zhang, L. Banerjee, K. see Saeed, B.O. Alberti, K.G.M.M. see Fischbacher, C.M. Bardelli, C. see Bo, S. Alberti, K.G.M.M. see Parker, L. Bardini, G. see Mannucci, E. Alberti, K.G.M.M. see Williams, J.W. Barnett, A.H. A review of basal insulins, 873 Alberti, K.G.M.M. see Zimmet, P. Barnett, A.H. see Bain, S.C. Albrecht, M. see Ortlepp, J.R. Barnett, A.H., Grant, P.J., Hitman, G.A., Mather, H., Pawa, M., Alcolado, J. see Channon, S. Robertson, L. & Trelfa, A. on behalf of the Indo-Asian Trial Aldington, S. see Harding, S. Investigators. Rosiglitazone in Type 2 diabetes mellitus: an Aldington, S.J. see Scanlon, P.H. evaluation in British Indo-Asian patients, 387 Alhenc-Gelas, F. see Hadjadj, S. Bartlett, W.A. see Al-Daghri, N. Allen, K.V. see Henderson, J.N. Barton, D.M., Baskar, V., Kamalakannan, D., Buch, H.N., Almind, K. see Pildal, J. Gone, K., Wilson, E., Anderson, J. & Abdu, T.A.M. An Alvarez, L. see Costa, A. assessment of care of paediatric and adolescent patients with Aman, J. see Ingberg, C-M. diabetes in a large district general hospital, 394 Amano, S. see Pang, H. Baskar, V. see Barton, D.M. Ambye, L. see Pildal, J. Basu, A., Kamal, A.D., Illahi, W., Khan, M., Stavrou, P. & Amiel, S.A. see Bingham, E. : Ryder, R.E.J. Is digital image compression acceptable within Amin, P. & Sturrock, N.D.C. A pilot study of the beneficial effects diabetic retinopathy screening?, 766 of amantadine in the treatment of painful diabetic peripheral Baxter, M. see Masson, E.A. neuropathy, 114 Beck-Nielsen, H. see Jensen, D.M. Amod, A. see Motala, A.A. Beck-Nielsen, H. see Staehr, P. Anderson, B. see Welch, G. Becker, D. see Bosnyak, Z. Anderson, J. see Barton, D.M. Bek, T. see Frystyk, J. Anderson, P. see Lunt, H. Ben Mehidi, A. see Massin, P. Anderson, R.L. see Mazze, R.S. Ben-Haroush, A. see Yogev, Y. Andreasen, A.H. see Nordly, S. Bengel, F.M. see Hattori, N. Anshoo, H. see Velmurugan, K. Bennett, S.M.A. see Parker, L. Aoki, T. see Yokoyama, H. Bergenstal, R.M. see Mazze, R.S. Araujo-Vilar, D. see Garcia-Estévez, D.A. Berghold, A. see Siebenhofer, A. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 1042 Indexes Berglund, G. see Gottsater, A. Briggs, A. see Clarke, P. Bergrem, H. see Schramm, W. Broadbent, D.M. see Younis, N. Berne, C. see Ingberg, C-M. Brown, K. see Saeed, B.O. Bhattarai, M.D. see Singh,D.L. Bruce, D.G. see Davis, T.M.E. Bhopal, R. see Fischbacher, C.M. de Bruin, T.W.A. see Mensink, M. Biermann, E. No evidence for accumulation of insulin glargine Brydon, P. see Dunne, F. (LANTUS), 333 Brydon, P. see Sinha, B. Biesenbach, G., Raml, A., Schmekal, B. & Eichbauer-Sturm, G. Buch, H.N. see Barton, D.M. Decreased insulin requirement in relation to GFR in nephropathic Buchanan, T.A. see Chong-Martinez, B. Type 1 and insulin-treated Type 2 diabetic patients, 642 Bihling, K.J. see Schaefer-Graf, U.M. Bingham, E., Hopkins, D., Pernet, A., Reid, H., Macdonald, I.A. & Bulsara, M. see Caplin, N.J. Amiel, S.A. The effects of KATP channel modulators on Bury, G. see Smith, $.M. counterregulatory responses and cognitive function during acute Busch, K. & Chantelau, E. Effectiveness of a new brand of stock controlled hypoglycaemia in healthy men: a pilot study, 231 ‘diabetic’ shoes to protect against diabetic foot ulcer relapse. A Birkeland, K.I., Kilhovd, B., Thorsby, P., Torjesen, P.A., Ganss, R., prospective cohort study, 665 Vaaler, S. & Hanssen, K.F. Heterogeneity of non-insulin- Buxton-Thomas, M.S. see Watkins, P.]. dependent diabetes expressed as variability in insulin sensitivity, Byrne, K. see McFarlane, S.I. B-cell function and cardiovascular risk profile, 37 Biswas, M. see Prakash, P.K. Cabezas-Cerrato, J. see Garcia-Estévez, D.A. Bjerle, P. see Lindmark, S. Caldwell, G. see Masson, E.A. Blaak, E.E. see Mensink, M. Cameron, A.J. see Williams, J.W. Bo, S., Menato, G., Pinach, S., Signorile, A., Bardelli, C., Lezo, A., Cameron, F.J., Smidts, D., Hesketh, K., Wake, M. & Northam, E.A. Marchisio, B., Gentile, L., Cassader, M., Massobrio, M. & Early detection of emotional and behavioural problems in Pagano, G. Clinical characteristics and outcome of pregnancy in children with diabetes: the validity of the Child Health women with gestational hyperglycaemia with and without Questionnaire as a screening instrument, 646 antibodies to B-cell antigens, 64 Campbell, L.V. see Kriketos, A.D. Bodansky, H.J. see Feltbower, R.G. Caplin, N.J., O’Leary, P., Bulsara, M., Davis, E.A. & Jones, T.W. Bodansky, H.J. see McKinney, P.A. Subcutaneous glucose sensor values closely parallel blood glucose Bolli, G. see Owens, D.R. during insulin-induced hypoglycaemia, 238 Borch-Johnsen, K. see Colagiuri, S. Carey, D.G. see Kriketos, A.D. Borch-Johnsen, K. see Pildal, J. Carr, L. see Scuffham, P. Borch-Johnsen, K. see Schramm, W. Carroll, C. see Dornan, T. Borch-Johnsen, K., Lauritzen, T., Gliimer, C. & Sandbeek, A. Carroll, C., Naylor, E., Marsden, P. & Dornan, T. How do people Screening for Type 2 diabetes—should it be now? 175 with Type 2 diabetes perceive and respond to cardiovascular risk? Bos, G. see Scheffer, P.G. 333 Bosnyak, Z., Forrest, K.Y.-Z., Maser, R.E., Becker, D. & Carstensen, B. see Colagiuri, S. Orchard, T.J. Do plasminogen activator inhibitor (PAI-1) or Carstensen, B. see Pildal, J. tissue plasminogen activator PAI-1 complexes predict Casals, E. see Costa, A. complications in Type 1 diabetes: The Pittsburgh Epidemiology Casamitjana, R. see Costa, A. of Diabetes Complications Study, 147 Cassader, M. see Bo, S. Botas, P., Delgado, E., Castafio, G., Diaz de Grefiu, C., Prieto, J. & Castano, G. see Botas, P. Diaz-Cadorniga, F.J. Comparison of the diagnostic criteria for Catto, A.J. see Kain, K. diabetes mellitus, WHO-1985, ADA-1997 and WHO-1999 in Cerimele, B. see Roach, P. the adult population of Asturias (Spain), 904 Cha, B.S. see Kim, D.]. Bott, U., Ebrahim, S., Hirschberger, $. & Skovlund, S.E. Effect of the Chan, J.C.N. see Ko, G.T.C. rapid-acting insulin analogue insulin aspart on quality of life and Chan, J.C.N. see Thomas, G.N. treatment satisfaction in patients with Type 1 diabetes, 626 Chan, W.B. see Ko, G.T.C. Boucher, B.J. Trends in the incidence of childhood diabetes in South Chang, H.-Y. see Pan, W.-H. Asians and other children in Bradford, UK, 602 Channon, S., Smith, V., Alcolado, J. & Gregory, J.W. Current Boulton, A.J.M. see Armstrong, D.G. methodso f transfer of young people with Type 1 diabetes to adult Boulton, A.J.M. see Dang, C.N. services, 1034 Bowers, A. see Manning, P.]J. Chantelau, E. see Busch, K. Boyce, K.S. see Mazze, R.S. Chatellier, G. see Hadjadj, S. Bragd,J .,A damson, U., Lins, P.-E., Wredling, R. & Oskarsson, P. A Chatterjee, S., Tsaloumas, M.D., Gee, H., Lipkin, G. & Dunne, F.P. repeated cross-sectional survey of severe hypoglycaemia in 178 From minimal background diabetic retinopathy to profuse sight Type 1 diabetes mellitus patients performed in 1984 and 1998, threatening vitreoretinal haemorrhage: management issues in a 216 case of pregestational diabetes and pregnancy, 683 Braithwaite, P.A. see Prakash, P.K. Chen, R. see Yogev, Y. Brash, P.D. see Masson, E.A. Chen, T.H-H. see Liu, W-J. Brauer, M. see Schaefer-Graf, U.M. Chisholm, D.J. see Kriketos, A.D. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 LV Indexes 1043 Chitson, P. see Williams, J.W. Dalfollo, M. see Inchiostro, S. Chiu, K.C., Chuang, L.-M., Chu, A. & Wang, M. Transcription Damm, P. see Jensen, D.M. factor 1 and B-cell function in glucose-tolerant subjects, 225 Dang, C. see Armstrong, D.G. Choi, D.S. see Choi, K.M. Dang, C.N., Prasad, Y.D.M., Boulton, A.J.M. & Jude, E.B. Choi, K.M., Lee, J., Kim, K.B., Kim, D.R., Kim, $.K., Shin, D.H., Methicillin-resistant Staphylococcus aureus in the diabetic foot Kim, N.H., Park, I.B., Choi, D.S. & Baik, $.H. Factor analysis of clinic: a worsening problem, 159 the metabolic syndrome among elderly Koreans—the South-west Dang, C.N., Prasad, Y.D.M., Connor, H. & Boulton, A.J.M. Seoul Study, 99 Update on the Diabetic Foot from Malvern Foot Conference Chong-Martinez, B., Buchanan, T.A., Wenby, R.B. & Meiselman, 2002, 245 H.J. Decreased red blood cell aggregation subsequent to Davey Smith, G. see Bachmann, M.O. improved glycaemic control in Type 2 diabetes mellitus, 301 Davies, H.A. see Patel, V.K. Christensen, J. see Colagiuri, S. Davies, S. see Ranice, J. Christie, D. see Viner, R.M. Davis, E.A. see Caplin, N.]. Chu, A. see Chiu, K.C. Davis, T.M.E., Mehta, Z., Mackay, I.R., Cull, C.A., Bruce, D.G., Chuang, L.-M. see Chiu, K.C. Fida, $., Rowley, M.J. & Holman, R.R. Autoantibodies to the Citroni, N. see Inchiostro, S. islet cell antigen SOX-13 are associated with duration but not Clark, M. & Hampson, S.E. Comparison of patients’ and healthcare type of diabetes, 198 professionals’ beliefs about and attitudes towards Type 2 De Venuto, G. see Inchiostro, S. diabetes, 152 Dean, H.J. see Kaila, B. Clarke, P., Gray, A., Legood, R., Briggs, A. & Holman, R. The Deary, LJ. see Henderson, J.N. impact of diabetes-related complications on healthcare costs: Deary, I.J. see McCrimmon, R.]J. results from the United Kingdom Prospective Diabetes Study Deary, I.J. see Sommerfield, A.J. (UKPDS Study No. 65), 442 Deary, I.J. see Strachan, M.W.J. Clarke, P. see Holt, R.L.G. Deary, I.J. see Taylor, M.D. Cockram, C.S. see Ko, G.T.C. Deepa, R. see Velmurugan, K. Cockram, C.S. see Thomas, G.N. Dekker, J.M. see Adriaanse, M.C. Colagiuri, $., Sandbek, A., Carstensen, B., Christensen, J., Glumer, Dekker, J.M. see Scheffer, P.G. C., Lauritzen, T. & Borch-Johnsen, K. Comparability of venous Delaney, P. see Treml, H. and capillary glucose measurements in blood, 953 Delgado, E. see Botas, P. Coleman, M.A.G. see Holt, R.LG. Demaine, A.G. see Zhao, H.X. Colquitt, J., Royle, P. & Waugh, N. Are analogue insulins better De Valk, H.W. see Goudswaard, A.N. than soluble in continuous subcutaneous insulin infusion? Results DeVries, J.H., Lindholm, A., Jacobsen, J.L., Heine, R.J. & of a meta-analysis, 863 Home, P.D. The Tri-Continental Insulin Aspart Study Group. Conget, I. see Costa, A. A randomized trial of insulin aspart with intensified basal NPH Connolly, V.M. see Vaidya, B. insulin supplementation in people with Type 1 diabetes, 312 Connor, H. see Dang, C.N. Dhindsa, P., Scott, A.R. & Donnelly, R. Metabolic and Coppin, D.V. see Spruce, M.C. cardiovascular effects of very-low-calorie diet therapy in obese Costa, A., Casamitjana, R., Casals, E., Alvarez, L., Morales, J., patients with Type 2 diabetes in secondary failure: outcomes after Masramon, X., Hernandez, G., Gomis, R. & Conget, I. Effects of 1 year, 319 atorvastatin on glucose homeostasis, postprandial triglyceride Diaz-Cadorniga, F.J. see Botas, P. response and C-reactive protein in subjects with impaired fasting Diaz de Gren, C. see Botas, P. glucose, 743 Dickinson, H.O. see Parker, L. de Courten, M.P. see Tapp, R.J. Diebler, F. see Roach, P. de Courten, M.P. see Williams, J.W. Dinneen, S.F. see Yuyun, M.F. Cox, J. see Valabhii, J. Dixon, A.F. see Dixon, J.B. Craft, A.W. see Parker, L. Dixon, J.B., Dixon, A.F., & O’Brien, P.E. Improvements in insulin Critchley, J.A.J.H. see Thomas, G.N. sensitivity and B-cell function (HOMA) with weight loss in the Croall, J. see Hassanein, M.M. severely obese, 127 Croft, D.J. see Hadden, D.R. Doll, H. see Farmer, A.J. Cromme, P. see Schramm, W. Dong, L. see Yang, X. Crosland, A. see Whitford, D.L. Donnelly, R. see Dhindsa, P. Cross, D. see Zhao, H.X. Donohoe, M. see Owen, K.R. Cruickshank, J.K. see Vyas, A. Dornan, T. see Carroll, C. Cull, C.A. see Davis, T.M.E. Dornan, T. & Carroll, C. Medical communication and diabetes, 85 Cull, C.A. see Hadden, D.R. Dornan, T.L. see Kaushal, K. Cundy, T. & Drury, P. Insulin-treated diabetes and driving in the Dreyer, M. see Roach, P. UK, 168 Drury, P. see Cundy, T. Czupryniak, L., Ruxer, J., Saryusz-Wolska, M. & Loba, J. Drury, P.L. see Manning, P.J. Discontinuing insulin therapy after diabetic ketoacidosis—is its Dudenhausen, J.W. see Schaefer-Graf, U.M. cause worth considering? 333 Duffy, S.W. see Liu, W-J. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 AV) 1044 Indexes Dunger, D.B. see Ford-Adams, M.E. Flyvbjerg, A. see Frystyk, J. Dunne, F., Brydon, P., Smith, K. & Gee, H. Pregnancy in women Ford-Adams, M.E., Murphy, N.P., Moore, E.J., Edge, J.A., Ong, with Type 2 diabetes: 12 years outcome data 1990-2002, 734 K.L., Watts, A.P., Acerini, C.L. & Dunger, D.B. Insulin lispro: a Dunne, C.J. see Mazze, R.S. potential role in preventing nocturnal hypoglycaemia in young Dunne, F. see Sinha, B. children with diabetes mellitus, 656 Dunne, F.P. see Chatterjee, S. Forrest, K.Y.-Z. see Bosnyak, Z. Dunstan, D.W. see Tapp, R.J. Forrester, J.V. see Olson, J.A. Dyer, P.H. see Bain, S.C. Foy, C. see Scanlon, P.H. Frankel, S$. see Bachmann, M.O. Eachus, J. see Bachmann, M.O. Frier, B.M. see Henderson, J.N. Ebrahim, S. see Bott, U. Frier, B.M. see McCrimmon, R.J. Edenborough, F.P. see Mackie, A.D.R. Frier, B.M. see Sommerfield, A.J. Edgar, K. see Skinner, T.C. Frier, B.M. see Strachan, M.W.J. Edge, J.A. see Ford-Adams, M.E. Frier, B.M. see Taylor, M.D. Edwards, O.M. see Yuyun, M.F. Frykberg, R.G. see Armstrong, D.G. Egberts, E.-H. see Holstein, A. Frystyk, J., Bek, T., Flyvbjerg, A., Skjarbak, C. & Orskov, H. The Eguchi, H. see Marugame, T. relationship between the circulating IGF system and the presence Eichbauer-Sturm, G. see Biesenbach, G. of retinopathy in Type 1 diabetic patients, 269 Eiger, G. see Kian, K. Furler, $.M. see Kriketos, A.D. van Eijk, J. Th.M. see Renders, C.M. Furlong, N.J., Hulme, $.A., O’Brien, $.V. & Hardy, K.J. ElBouri, K. see Prakash, P.K. Comparison of repaglinide vs. gliclazide in combination with Elkeles, R.S. see Valabhii, J. bedtime NPH insulin in patients with Type 2 diabetes Ellard, S$. see Owen, K.R. inadequately controlled with oral hypoglycaemic agents, 935 Elwig, C. see Valabhii, J. Enas, E.A. see Velmurugan, K. Gallen, I.W. see Masson, E.A. Erginay, A. see Massin, P. Gallois, Y. see Hadjadj, S. Eriksson, J.W. see Lindmark, S. Ganss, R. see Birkeland, K.I. Ernst, E. see Schmidt, K. Garcia-Estévez, D.A., Aratijo-Vilar, D., Fiestras-Janeiro, G., Espiner, E.A. see Manning, P.J. Saavedra-Gonzalez, A. & Cabezas-Cerrato, J. Insulin resistance Evans, J. see Tang, E.W. in essential hypertension: a conflictive point of view, 1035 Ewing, F.M.E. see McCrimmon, R.J. Gaudric, A. see Massin, P. Ewing, F.M.E. see Sommerfield, A.J. Gee, H. see Chatterjee, S. Ewins, D.L. see Hassanein, M.M. Gee, H. see Dunne, F. Gentile, L. see Bo, S. Fait, D. see Inchiostro, S. Gibson, J. see Harding, S. Fall, C.H.D. see Newsome, C.A. Gibson, J.M. see Kaushal, K. Farmer, A.J., Doll, H., Levy, J.C. & Salkovskis, P.M. The impact of Gilbert, R.E. see Krum, H. screening for Type 2 diabetes in siblings of patients with Gilbert, R.E., Krum, H., Wilkinson-Berka, J. & Kelly, D.J. The established diabetes, 996 renin-angiotensin system and the long-term complications of Feest, T. see Schramm, W. diabetes: pathophysiological and therapeutic considerations, 607 Feher, M.D. see Treml, H. Gill, G.V. see Bain, S.C. Feldt-Rasmussen, B. see Schramm, W. Gill, S. see Vyas, A. Feltbower, R.G. see McKinney, P.A. Giorgino, F. see Greco, P. Feltbower, R.G., McKinney, P.A., Parslow, R.C., Stephenson, C.R. Gliimer, C. see Borch-Johnsen, K. & Bodansky, H.J. Type 1 diabetes in Yorkshire, UK: time trends Glumer, C. see Colagiuri, S. in 0-14 and 15-29-year-olds, age at onset and age-period-cohort Goatman, K.A. see Olson, J.A. modelling, 437 Goddard, J.R. see Holt, R.I.G. Feskens, E.J.M. see Mensink, M. Gold, A.E. see McCrimmon, R.]. Fida, S. see Davis, T.M.E. Gold, A.E. see Taylor, M.D. Fiestras-Janeiro, G. see Garcia-Estévez, D.A. Gomis, R. see Costa, A. Firth, R.G. see Smith, $.M. Gone, K. see Barton, D.M. Fischbacher, C.M., Bhopal, R., Rutter, M.K., Unwin, N.C., Gottsater, A., Rydén-Ahlgren, A., Szelag, B., Hedblad, B., Persson, Marshall, $.M., White, M. & Alberti, K.G.M.M. Microalbuminuria J., Berglund, G., Wroblewski, M. & Sundkvist, G. is more frequent in South Asian than in European origin Cardiovascular autonomic neuropathy associated with carotid populations: a comparative study in Newcastle, UK, 31 atherosclerosis in Type 2 diabetic patients, 495 Fisher, M. see Winocour, P.H. Goudswaard, A.N., Stolk, R.P., de Valk, H.W. & Rutten, G.E.H.M. Florkowski, C.M., Scott, R.S., Graham, P.J., Han, D.Y. & Moir, Improving glycaemic control in patients with Type 2 diabetes C.L. Cause-specific and total mortality in the Canterbury (New mellitus without insulin therapy, 540 Zealand) insulin-treated Diabetic Registry population: a 15-year Gough, K. see Strachan, M.W.J. follow-up study, 191 Gouws, E. see Motala, A.A. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 LV Indexes 1045 Graham, P.J. see Florkowski, C.M. Henderson, J.N., Allen, K.V., Deary, LJ. & Frier, B.M. Grant, P.J. see Barnett, A.H. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, Grant, P.J. see Kain, K. symptoms and impaired awareness, 1016 Gray, A. see Clarke, P. Henrich, W. see Schaefer-Graf, U.M. Greco, P., Vimercati, A., Hyett, J., Rossi, A.C., Scioscia, M., Hepburn, D.A. see McCrimmon, R.]. Giorgino, F., Loverro, G. & Selvaggi, L. The ultrasound Hermann, N. see Nordly, S. assessment of adipose tissue deposition in fetuses of ‘well Hermus, A.R. see Pouwels, M.-J.J. controlled’ insulin-dependent diabetic pregnancies, 858 Hernandez, G. see Costa, A. Greene, S. see Skinner, T.C. Hesketh, K. see Cameron, F.]. Greenwood, R. see Harding, S. Hey, S. see Viner, R.M. Gregory, J.W. see Channon, S. Hipwell, J.H. see Olson, J.A. Griffin, S.J. see Rahman, M. Hirasawa, K. see Yokoyama, H. Gudat, U. see Roach, P. Hirschberger, S. see Bott, U. Guillausseau, P.J. see Massin, P. Hitman, G.A. see Barnett, A.H. Ho, L.-T. see Pan, W.-H. Hadden, D.R., Cull, C.A., Croft, D.J. & Holman, R.R. Poor Hod, M. see Yogev, Y. pregnancy outcome for women with Type 2 diabetes, 506 Hod, R. see Siebenhofer, A. Hadjadj, S., Gallois, Y., Alhenc-Gelas, F., Chatellier, G. & Marre, M. HOE 901/2004 Study Investigators Group. Safety and efficacy for the DZABHYCAR Study Group. Angiotensin-I-converting of insulin glargine (HOE 901) versus NPH insulin in combination enzyme insertion/deletion polymorphism and high urinary with oral treatment in Type 2 diabetic patients, 545 albumin concentration in French Type 2 diabetes patients, 677 Hoffmann, R. see Ortlepp, J.R. Hahn, J.S. see Kim, D.J. Hojlund, K. see Staehr, P. Haidery, A.Z. see Vyas, A. Holdaway, I.M. see Manning, P.J. Hampson, S.E. see Clark, M. Hollins, A. see Sinha, B. Hamulyak, K. see Leurs, P.B. Holman, R. see Clarke, P. Han, D.Y. see Florkowski, C.M. Holman, R.R. see Davis, T.M.E. Hanna, F.W. see Prakash, P.K. Holman, R.R. see Hadden, D.R. Hanrath, P. see Ortlepp, J.R. Holohan, J. see Smith, $.M. Hansen, K.W., Poulsen, P.L. & Mogensen, C.E. Ambulatory blood Holst, J.J. see Staehr, P. pressure monitoring, 509 Holstein, A., Plaschke, A. & Egberts, E.-H. Use of insulin glargine Hansen, S.K. see Pildal, J. during embryogenesis in a pregnant woman with Type 1 diabetes, 579 Hansen,T. see Pildal, J. Hanssen, K.F. see Birkeland, K.1 Holt, R.I.G., Goddard, J.R., Clarke, P. & Coleman, M.A.G. A Harding, S., Greenwood, R., Aldington, S., Gibson, J., Owens, D., postnatal fasting plasma glucose is useful in determining which Taylor, R., Kohner, E., Scanlon, P. & Leese, G. The Diabetic women with gestational diabetes should undergo a postnatal oral Retinopathy Grading and Disease Management Working Party. glucose tolerance test, 594 Grading and disease management in national screening for Holt, R.1.G., Simpson, H.L. & Sénksen, P.H. The role of the growth diabetic retinopathy in England and Wales, 965 hormone-insulin-like growth factor axis in glucose homeostasis, Harding, S.P. see Younis, N. >? Hardy, K.J. see Furlong, N.J. Home, P.D. see DeVries, J.H. Hardy, K.J. see Moulik, P.K. Hopkins, D. see Bingham, E. Harney, B. see Scanlon, P.H. Hopper, C.D. see Bachmann, M.O. Harvey, R. see Morris, A. Hother-Nielsen, O. see Staehr, P. Hassanein, M.M., Croall, J., Ewins, D.L. & Worth, R.C. An Hounsome, B. see Kaushal, K. unusual cause of diabetic ketoacidosis and fulminant septicaemia, Howard, E.R. see Watkins, P.]J. 242 Howells, L. see Skinner, T.C. Hattersley, A.T. see Owen, K.R. Hsu-Hage, B.H.-H. see Yang, X. Hattori, N., Rihl,J .,B engel, F.M., Nekolla, S.G., Standl, E., Schwaiger, M. Hughes, P. see Zhao, H.X. & Schnell, O. Cardiac autonomic dysinnervation and myocardial Huh, K.B. see Kim, D.J. blood flow in long-term Type 1 diabetic patients, 375 Hulme, S.A. see Furlong, N.J. Hayasaki, H. see Marugame, T. Hwu, C.-M. see Pan, W.-H. Hedblad, 8. see Gottsater, A. Hyett, I. see Greco, P. Heine, R.J! see Adriaanse, M.C. Heine, R.J. see DeVries, J.H. Idrogo, M.A. see Mazze, R.S. Heine, R.J. see Renders, C.M. Illahi, W. see Basu, A. Heine, R.J. see Scheffer, P.G. Inagaki, Y. see Pang, H. Heinze, T. see Schaefer-Graf, U.M. Inchiostro, S., Dalfollo, M., Marzano, A., Citroni, N., Peccatori, S., Heise, T. on behalf of the authors. Reply, 334 Fait, D. & De Venuto, G. Prevalence of diabetes and/or ischaemic Heller, S. The National Service Framework for Diabetes: a glass half heart disease in classes of increasing carotid artery empty or half full? 173 atherosclerosis: an ultrasonographic study, 670 © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 1046 Indexes Ingberg, C.-M., Sarnblad, S., Palmér, M., Schvarcz, E., Berne, C. & Kimura, H. see Pang, H. Aman, J. Body composition in adolescent girls with Type 1 Kirkpatrick, J.N. see Scanlon, P.H. diabetes, 1005 Kjos, $.L. see Schaefer-Graf, U.M. Inukai, T. see Aso, Y. Klepper, J. see Willemsen, M.A.A.P. Ishiyama, M. see Yokoyama, H. Ko, G.T.C., Lee, S.C., Pu, Y.B., Ng, M.C.Y., So, W.-Y., Thomas, N., Chan, W.B., Cockram, C.S. & Chan, J.C.N. Tumour necrosis Jacobsen, J.L. see DeVries, J.H. factor-alpha promoter gene polymorphism at -308 (genotype AA) Jacome de Castro, J. see Macedo, A. in Chinese subjects with Type 2 diabetes, 167 Jagannathan, N.R. see Misra, A. Kobayashi, I. see Aso, Y. Jardine, D.L. see Tang, E.W. Koda, Y. see Pang, H. Jenkins, A.B. see Kriketos, A.D. Kohner, E. see Harding, S. Jenkins, D. see Sinha, B. Konopatskaya, O., Whatmore, J.L., Tooke, J.E. & Shore, A.C. Jensen, D.M., Damm, P., Sorensen, B., Molsted-Pedersen, L., Insulin and lysophosphatidylcholine synergistically stimulate Westergaard, J.G., Korsholm, L., Ovesen, P. & Beck-Nielsen, H. NO-dependent cGMP production in human endothelial cells, 838 Proposed diagnostic thresholds for gestational diabetes mellitus von Korff, A. see Ortlepp, J.R. according to a 75-g oral glucose tolerance test. Maternal and Korsholm, L. see Jensen, D.M. perinatal outcomes in 3260 Danish women, 51 Koyama, K. see Yokoyama, H. Jick, H. see Wood, S.L. Kriegsman, D.M.W. see Renders, C.M. Johansson, A. see Skinner, T.C. Kriketos, A.D., Carey, D.G., Jenkins, A.B., Chisholm, D.J., Furler, Jones, A.F. see Al-Daghri, N. S.M. & Campbell, L.V. Central fat predicts deterioration of Jones, A.F. see Bain, S.C. insulin secretion index and fasting glycaemia: 6-year follow-up of Jones, K.E. see Bain, S.C. subjects at varying risk of Type 2 diabetes mellitus, 294 Jones, T.W. see Caplin, N.J. Kruijshoop, M. see Mensink, M. Jorge, Z. see Macedo, A. Krum, H. see Gilbert, R.E. Jorgensen, T. see Nordly, S. Krum, H., Skiba, M. & Gilbert, R.E. Comparative metabolic effects Jude, E.B. see Dang, C.N. of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy, 708 Kaila, B., Dean, H.J., Schroeder, M. & Taback, $.P. HLA, day care Krzentowski, G. see Zhang, L. attendance, and socio-economic status in young patients with Kumar, M. see Misra, A. Type 1 diabetes, 777 Kumar, S. see Al-Daghri, N. Kain, K., Catto, A.J. & Grant, P.J. Associations between insulin resistance and thrombotic risk factors in high-risk South Asian Lacerda Nobre, E. see Macedo, A. subjects, 651 Lahousen, T., Lipp, R.W. & Schnedl, W.JJ. Can hyperglycaemia Kamal, A.D. see Basu, A. cause jejuno-jejunal intussusception?, ~5 335 Kamalakannan, D. see Barton, D.M. Lajer, M. see Pildal, J. Kanda, T. see Aso, Y. Lamont, D.W. see Parker, L. Kaplan, B. see Yogev, Y. Lamont, S.S. see Whitford, D.L. Kaushal, K. & Dornan, T.L. Evidence-Based Diabetes Care, 510 Landgraf, R. see Schramm, W. Kaushal, K., Gibson, J.M., Railton, A., Hounsome, B., New, J.P. & Lauritzen, T. see Borch-Johnsen, K. Young, R.J. A protocol for improved glycaemic control following Lauritzen, T. see Colagiuri, S. corticosteroid therapy in diabetic pregnancies, 73 Law, C.M. see Newsome, C.A. Kearney, M.T. see Wheatcroft, S.B. Lawrence, J.B. see Velmurugan, K. Kelly, D.J. see Gilbert, R.E. Lean, M.E.J. The implementation of nutritional advice for people Kelly, W.F. see Vaidya, B. with diabetes, 783 Kendall, D. see Lunt, H. Lee, H.C. see Kim, D.]J. Kendall, D.M. see Mazze, R.S. Lee, J. see Choi, K.M. Khan, M. see Basu, A. Lee, K. see Marugame, T. Kian, K. & Eiger, G. Anticoagulant therapy in hyperosmolar non- Lee, L-T. see Liu, W-J. ketotic diabetic coma, 603 Lee, §.C.. see Ko,'G. F.C. Kilhovd, B. see Birkeland, K.I. Leese, G. see Harding, S. Kim, D.J., Kim, Y.M., Yun, Y.S., Ahn, C.W., Cha, B.S., Song, Y.D., Leese, G. see Morris, A. Lim, S.K., Kim, K.R., Hahn, J.S., Huh, K.B. & Lee, H.C. Leese, G.P., Morris, A.D. & Olson, J. A national retinal screening Therapeutic effect of recombinant human erythropoietin on programme for diabetes in Scotland, 962 anaemia with erythropoietin deficiency in diabetic patients, 661 Lefébvre, P.J. see Zhang, L. Kim, D.R. see Choi, K.M. Legood, R. see Clarke, P. Kim, K.B. see Choi, K.M. Leurs, P.B., van Oerle, R., Hamulyak, K. & Wolffenbuttel, B.H.R. Kim, K.R. see Kim, D.]. Tissue factor pathway inhibitor (TFPI) release after heparin Kim, N.H. see Choi, K.M. stimulation is increased in Type 1 diabetic patients with Kim, S.K. see Choi, K.M. albuminuria, 16 Kim, Y.M. see Kim, D.]J. Levy, J.C. see Farmer, A.J. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 [pe Indexes 1047 Lewis-Barned, N. see Scanlon, P.H. Masramon, X. see Costa, A. Lezo, A. see Bo, S. Massin, P., Erginay, A., Ben Mehidi, A., Vicaut, E., Quentel, G., Lim, S.K. see Kim, D.J. Victor, Z., Marre, M., Guillausseau, P.J. & Gaudric, A. Lindholm, A. see DeVries, J.H. Evaluation of an ew non-mydriatic digital camera for detection of Lindmark, S., Wiklund, U., Bjerle, P. & Eriksson, J.W. Does the diabetic retinopathy, 635 autonomic nervous system play a role in the development of Massobrio, M. see Bo, S. insulin resistance? A study on heart rate variability in first-degree Masson, E.A., Patmore, J.E., Brash, P.D., Baxter, M., Caldwell, G., relatives of Type 2 diabetes patients and control subjects, 399 Gallen, I.W., Price, P.A., Vice, P.A., Walker, J.D. & Lindow, S.W. Lindow, S.W. see Masson, E.A. Pregnancy outcome in Type 1 diabetes mellitus treated with Lindstrom, J. see Qiao, Q. insulin lispro (Humalog), 46 Lins, P.-E. see Bragd, J. Mather, H. see Barnett, A.H. Lipkin, G. see Chatterjee, S. Mathers, J.C. see Parker, L. Lipp, R.W. see Lahousen, T. Matsumoto, S. see Marugame, T. Liu, W-J., Lee, L-T., Yen, M-F., Tung, T-H., Williams, R., Duffy, Mattock, M.B. see Pickup, J.C. S.W. & Chen, T.H-H. Assessing progression and efficacy of Mazze, R.S., Simonson, G.D., Robinson, R.L., Kendall, D.M., treatment for diabetic retinopathy following the proliferative Idrogo, M.A., Adlis, $.A., Boyce, K.S., Dunne, C.J., Anderson, pathway to blindness: implication for diabetic retinopathy R.L. & Bergenstal, R.M. Characterizing blood pressure control in screening in Taiwan, 727 individuals with Type 2 diabetes: the relationship between clinic Loba, J. see Czupryniak, L. and self-monitored blood pressure, 752 Lovelock, L. see Arun, C.S. McAuliffe, A. see Smith, $.M. Loverro, G. see Greco, P. McCrimmon, R.J., Deary, I.J., Gold, A-E., Hepburn, D.A., Lunt, H., Kendall, D., Anderson, P., Willis, J.A. & Moore, M.P. MacLeod, K.M., Ewing, F.M.E. & Frier, B.M. Symptoms Prevalence of microvascular complications in adolescents with reported during experimental hypoglycaemia: effect of method of Type 1 diabetes, 421 induction of hypoglycaemia and of diabetes per se, 507 Lutterman, J.A. see Pouwels, M.-J.J. McCulloch, A.J. see Razvi, S. Lysiak-Szydtowska, W. see Rachon, D. McDonald, D. see Moore, K.B. McEvilly, A. see Skinner, T.C. Macdonald, I.A. see Bingham, E. McFarlane, S.I., Shin, J., Byrne, K. & Williams, R. Reply, 336 Macedo, A., Jorge, Z., Lacerda Nobre, E., Pratas, $. & Jacome de McHardy, K.C. see Olson, J.A. Castro, J. Prevalence of Type 1 diabetes mellitus in Portugal, McKenna, K. see Moore, K.B. 1995-1999: cohort of young men, 418 McKibbin, M.A. see Agrawal, A. Mackay, I.R. see Davis, T.M.E. McKinney, P.A., Feltbower, R.G. & Bodansky, H.J. Reply, 602 Mackie, A.D.R., Thornton, S.J. & Edenborough, F.P. Cystic McKinney, P.A. see Feltbower, R.G. fibrosis-related diabetes, 425 McKnight, J.A. see Strachan, M.W.]. MacLeod, K.M. see McCrimmon, R.]. Mehta, Z. see Davis, T.M.E. Mair, G. see Penney, G.C. Meiselman, H.J. see Chong-Martinez, B. Malhotra, R. see Scanlon, P.H. Menato, G. see Bo, S. Manfrini, S. see Pozzilli, P. Mensink, M., Feskens, E.J.M., Kruijshoop, M., de Bruin, T.W.A., Mankovsky, B.N., Piolot, R., Mankovsky, O.L. & Ziegler, D. Saris, W.H.M. & Blaak, E.E. Subscapular skinfold thickness Impairment of cerebral autoregulation in diabetic patients with distinguishes between transient and persistent impaired glucose cardiovascular autonomic neuropathy and orthostatic tolerance: Study on Lifestyle-Intervention and Impaired Glucose hypotension, 119 Tolerance Maastricht (SLIM), 552 Mankovsky, O.L. see Mankovsky, B.N. Metrikat, J. see Ortlepp, J.R. Manning, P.J., Espiner, E.A., Yoon, K., Drury, P.L., Holdaway, I.M. Millward, B.A. see Zhao, H.X. & Bowers, A. An unusual cause of hyperinsulinaemic Misra, A., Sinha, S., Kumar, M., Jagannathan, N.R. & Pandey, hypoglycaemia syndrome, 772 R.M. Proton magnetic resonance spectroscopy study of soleus Mannucci, E., Bardini, G., Rotella, F. & Rotella, C.-M. Comparison muscle in non-obese healthy and Type 2 diabetic Asian Northern among different insulin sensitivity indices in obese patients, 462 Indian males: high intramyocellular lipid content correlates with Marchisio, B. see Bo, S. excess body fat and abdominal obesity, 361 Marre, M. see Hadjadi, S. Mogensen, C.E. see Hansen, K.W. Marre, M. see Massin, P. Mohan, V. see Velmurugan, K. Marsden, P. see Carroll, C. Moir, C.L. see Florkowski, C.M. Marshall, $.M. see Fischbacher, C.M. Molsted-Pedersen, L. see Jensen, D.M. Marugame, T., Hayasaki, H., Lee, K., Eguchi, H. & Matsumoto, S. Moore, E.J. see Ford-Adams, M.E. Alveolar bone loss associated with glucose tolerance in Japanese Moore, K.B., McKenna, K., Tormey, W.P., McDonald, D. & men, 746 Thompson, C.J. The albuminuric action of atrial natriuretic Marzano, A. see Inchiostro, S. peptide is not modified by ACE-inhibition with perindopril in Maser, R.E. see Bosnyak, Z. Type 2 diabetes, 713 Mason, J. National screening for diabetic vetinopathy: clear vision Moore, M.P. see Lunt, H. needed, 959 Morales, J. see Costa, A. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 Vi 1048 Indexes Morris, A., Slattery, J., Olson, J., Leese, G. & Harvey, R. Olson, J.A., Strachan, F.M., Hipwell, J.H., Goatman, K.A., Current status of screening for diabetic retinopathy in the UK, McHardy, K.C., Forrester, J.V. & Sharp, P.F. A comparative 603 evaluation of digital imaging, retinal photography and Morris, A.D. see Leese, G.P. optometrist examination in screening for diabetic retinopathy, Mortensen, H.B. see Nordly, S. 528 Motala, A.A., Pirie, F.J., Gouws, E., Amod, A. & Omar, M.A.K. Omar, M.A.K. see Motala, A.A. High incidence of Type 2 diabetes mellitus in South African Ong, K.L. see Ford-Adams, M.E. Indians: a 10-year follow-up study, 23 Orchard, T.J. see Bosnyak, Z. Moulik, P.K. & Hardy, K.J. Hypertension, anti-hypertensive drug Orskov, H. see Frystyk, J. therapy and erectile dysfunction in diabetes, 290 Ortlepp, J.R., Metrikat, J., Albrecht, M., von Korff, A., Hanrath, P. Mukherjee, S. see Sharp, P.S. & Hoffmann, R. The vitamin D receptor gene variant and Munro, A. see Sinha, B. physical activity predicts fasting glucose levels in healthy young Murphy, M. see Bain, S.C. men, 451 Murphy, N.P. see Ford-Adams, M.E. Osawa, K. see Ota, T. Myers, L. see Razvi, S. Oskarsson, P. see Bragd, J. Mysliwska, J. see Rachon, D. Ota, T. & Osawa, K. Marked improvement of glycaemic control with pioglitazone in a Type 2 diabetic patient associated with Nagai,Y. , Nakatsumi,Y., Abe, T. & Nomura, G. Is the severity of Charcot—Marie—Tooth disease, 420 obstructive sleep apnoea associated with the degree of insulin Ovesen, P. see Jensen, D.M. resistance? 81 Owen, K.R., Donohoe, M., Ellard, $. & Hattersley, A.T. Response Nagai, Y., Sugiyama, Y., Nakatsumi, Y., Abe, T. & Nomura, G. to treatment with rosiglitazone in familial partial lipodystrophy Rapid amelioration of muscle sympathetic nerve activity by due to a mutation in the LMNA gene, 823 pioglitazone in an obese Type 2 diabetic patient, 868 Owen, K.R., Roland, J., Smith, K. & Hattersley, A.T. Adolescent Nakatsumi, Y. see Nagai,Y . onset Type 2 diabetes in a non-obese Caucasian patient with an Naylor, E. see Carroll, C. unbalanced translocation, 483 Neal, R.D. see Alazri, M.H. Owens, D. see Harding, S. Nekolla, $.G. see Hattori, N. Owens, D.R., Zinman, B. & Bolli, G. Alternative routes of insulin New, J.P. see Kaushal, K. delivery, 886 New, J.P. see Tieszen, K.L. Newsome, C.A., Shiell, A.W., Fall, C.H.D., Phillips, D.I.W., Shier, R. Padfield, P.L. see Strachan, M.W.]. & Law, C.M. Is birth weight related to later glucose and insulin Pagano, G. see Bo, S. metabolism?—a systematic review, 339 Palmér, M. see Ingberg, C-M. Ng, L.L. see Siebenhofer, A. Pan, W.-H., Yeh, W.-T., Chang, H.-Y., Hwu, C.-M. & Ho, L.-T. Ng, M.C.Y. see Ko, G.T.C. Prevalence and awareness of diabetes and mean fasting glucose by Ngugi, N. see Arun, C.S. age, sex, and region: results from the Nutrition and Health Survey Nijpels, G. see Adriaanse, M.C. in Taiwan, 1993-1996, 182 Nixon, B.P. see Armstrong, D.G. Pandey, R.M. see Misra, A. Nixon, S.J. see Saeed, B.O. Pang, H., Koda, Y., Yamagishi, $.-I., Amano, S., Inagaki, Y., Nomura, G. see Nagai,Y . Okamoto, T., Yamada, K. & Kimura, H. N-acetylglucosamine- Nordly, S., Jorgensen, T., Andreasen, A.H., Hermann, N. & phosphate mutase genotype and diabetic microvascular Mortensen, H.B. Quality of diabetes management in children and complications, 419 adolescents in Denmark, 568 Park, I.B. see Choi, K.M. Norgaard, K. A nationwide study of continuous subcutaneous Parker, L., Lamont, D.W., Unwin, N., Pearce, M.S., Bennett, insulin infusion (CSII) in Denmark, 307 S.M.A., Dickinson, H.O., White, M., Mathers, J.C., Alberti, Nomura, G. see Nagai, Y. K.G.M.M. & Craft, A.W. A lifecourse study of risk for Northam, E.A. see Cameron, F.]J. hyperinsulinaemia, dyslipidaemia and obesity (the central Nutrition Subcommittee of the Diabetes Care Advisory Committee metabolic syndrome) at age 49-51 years, 406 of Diabetes UK. The implementation of nutritional advice for Parkin, T. & Skinner, T.C. Discrepancies between patient and people with diabetes, 786 professionals recall and perception of an outpatient consultation, 909 O’Brien, P.E. see Dixon, J.B. Parslow, R.C. see Feltbower, R.G. O’Brien, S.V. see Furlong, N.J. Patel, V.K. & Davies, H.A. Insulin resistance Type A and short Sth O’Leary, M. see Smith, $.M. metacarpals, 500 O'Leary, P. see Caplin, N.J. Patmore, J.E. see Masson, E.A. O’Malley, B. see Rance, J. Patton, K. see Razvi, S. van Oerle, R. see Leurs, P.B. Pawa, M. see Barnett, A.H. Okamoto, T. see Pang, H. Pearce, M.S. see Parker, L. Okumura, K. see Aso, Y. Pearson, D.W.M. see Penney, G.C. Olson,J . see Leese, G.P. Pearson, N.J. see Bachmann, M.O. Olson, J. see Morris, A. Peccatori, S. see Inchiostro, S. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041 LV Indexes 1049 Pedersen, O. see Pildal, J. Rahman, M., Griffin, $.J., Rathmann, W. & Wareham, N.J. How Pein, M. see Roach, P. should peripheral neuropathy be assessed in people with diabetes Penney, G.C., Mair, G. & Pearson, D.W.M. The relationship between in primary care? A population-based comparison of four birth weight and maternal glycated haemoglobin (HbA,..) measures, 368 concentration in pregnancies complicated by Type 1 diabetes, 162 Railton, A. see Kaushal, K. Pernet, A. see Bingham, E. Rainbow, S. see Sharp, P.S. Persson, J. see Gottsater, A. Ramachandran, A., Snehalatha, C., Satyavani, K. & Vijay, V. Pfohl, U. see Zimny, S. Impaired fasting glucose and impaired glucose tolerance in urban Phillip, M. see Yogev, Y. population in India, 220 Phillips, C. see Rance, J. Raml, A. see Biesenbach, G. Phillips, D.I.W. see Newsome, C.A. Rance, J., Phillips, C., Davies, S., O’Malley, B., Zaman, Q. & Price, Picardi, A. see Pozzilli, P. D. How much of a priority is treating erectile dysfunction? A Pickup, J.C. & Mattock, M.B. Activation of the innate immune study of patients’ perceptions, 205 system as a predictor of cardiovascular mortality in Type 2 Rathmann, W. see Rahman, M. diabetes mellitus, 723 Ravikumar, R. see Velmurugan, K. Pickup, J.C. see Sachedina, N. Razvi, S., Myers, L., Patton, K. & McCulloch, A.J. Screening for Pieber, T.R. see Siebenhofer, A. diabetic retinopathy: a cause for concern in people who drive, 812 Pildal,J. , Lajer, M., Hansen, $.K., Almind, K., Ambye, L., Borch- Reid, H. see Bingham, E. Johnsen, K., Carstensen, B., Hansen,T. & Pedersen, O. Studies of Renders, C.M., Valk, G.D., de Sonnaville, J.J.J., Twisk, J., variability in the islet amyloid polypeptide gene in relation to Kriegsman, D.M.W., Heine, R.J., van Eijk, J.T h.M. & van der Type 2 diabetes, 491 Wal, G. Quality of care for patients with Type 2 diabetes Pinach, S. see Bo, S. mellitus—a long-term comparison of two quality improvement Piolot, R. see Mankovsky, B.N. programmes in the Netherlands, 846 Pirie, F.J. see Motala, A.A. Rihl, J. see Hattori, N. Plank, J. see Siebenhofer, A. Roach, P., Woodworth,J. ,G udat, U., Cerimele, B., Diebler, F., Pein, Plaschke, A. see Holstein, A. M. & Dreyer, M. A 75% insulin lispro/25% NPL mixture van der Ploeg, H.M. see Adriaanse, M.C provides a longer duration of insulin activity compared with Polonsky, W.H. see Welch, G. insulin lispro alone in patients with Type 1 diabetes, 946 Potter, J. see Spruce, M.C. Roberts, C. see Vyas, A. Poulsen, P.L. see Hansen, K.W. Robertson, L. see Barnett, A.H. Poulter, C. see Valabhji, J. Robinson, R.L. see Mazze, R.S. Pouwels, E. see Willemsen, M.A.A.P. Rodins, K. see Tang, E.W. Pouwels, M.-J.J., Tack, C.J., Hermus, A.R. & Lutterman, J.A. Roland, J. see Owen, K.R. Treatment with intravenous insulin followed by continuous Roper, N.A. see Vaidya, B. subcutaneous insulin infusion improves glycaemic control in Rosenthal, M. see Baldeweg, S.E. severely resistant Type 2 diabetic patients, 76 Rossi, A.C. see Greco, P. Pozzilli, P., Manfrini, $. & Picardi, A. Cow’s milk and trials for Rotella, C.M. see Mannucci, E. prevention of Type | diabetes, 871 Rotella, F. see Mannucci, E. Prakash, P.K., Biswas, M., ElBouri, K., Braithwaite, P.A. & Rowley, M.J. see Davis, T.M.E. Hanna, F.W. Pneumococcal necrotizing fasciitis in a patient with Royle, P. see Colquitt, J. Type 2 diabetes, 899 Rutten, G.E.H.M. see Goudswaard, A.N. Prasad, Y.D.M. see Dang, C.N. Rutter, M.K. see Fischbacher, C.M. Pratas, S. see Macedo, A. Ruxer, J. see Czupryniak, L. Price, D. see Rance, J. Rydén-Ahlgren, A. see Gottsater, A. Price, P.A. see Masson, E.A. Ryder, R.E.J. see Basu, A. Prieto, J. see Botas, P. Propper, C. see Bachmann, M.O. Saavedra-Gonzalez, A. see Garcia-Estévez, D.A. Pu, Y.B. see Ko, G.T.C. Saeed, B.O., Banerjee, K., Nixon, S.J. & Brown, K. Plasma homocysteine concentrations in patients with Type 1 diabetes, Qiao, Q., Lindstr6émJ,. , Valle, T.T. & Tuomilehto,J . Progression to 867 clinically diagnosed and treated diabetes from impaired glucose Sachedina, N. & Pickup, J.C. Performance assessment of the tolerance and impaired fasting glycaemia, 1027 Medtronic-MiniMed Continuous Glucose Monitoring System Qin, Y.-W. see Zhang, J.-L. and its use for measurement of glycaemic control in Type 1 Qiu, J.-L. see Zhang, J.-L. diabetic subjects, 1012 Quentel, G. see Massin, P. Salkovskis, P.M. see Farmer, A.J. Sandbek, A. see Borch-Johnsen, K. Rachon, D., Mysliwska, J., Suchecka-Rachon, K., Semetkowska- Sandbek, A. see Colagiuri, S. Jurkiewicz, B., Zorena, K. & tysiak-Szydtowska, W. Serum Sanderson, E. see Zhao, H.X. interleukin-6 levels and bone mineral density at the femoral neck Saris, W.H.M. see Mensink, M. in post-menopausal women with Type 1 diabetes, 475 Sarnblad, S. see Ingberg, C-M. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055 Vi 1050 Indexes Saryusz-Wolska, M. see Czupryniak, L. Sinha, B., Brydon, P., Taylor, R.S., Hollins, A., Munro, A., Jenkins, D. Satyavani, K. see Ramachandran, A. & Dunne, F. Maternal ante-natal parameters as predictors of Sauve, R. see Wood, S.L. persistent postnatal glucose intolerance: a comparative study Scanlon, P. see Harding, S. between Afro-Caribbeans, Asians and Caucasians, 382 Scanlon, P.H., Malhotra, R., Thomas, G., Foy, C., Kirkpatrick, J.N., Sinha, S. see Misra, A. Lewis-Barned, N., Harney, B. & Aldington, S.J. The effectiveness Skiba, M. see Krum, H. of screening for diabetic retinopathy by digital imaging Skinner, T.C., Howells, L., Greene, S., Edgar, K., McEvilly, A. & photography and technician ophthalmoscopy, 467 Johansson, A. Development, reliability and validity of the Schaefer-Graf, U.M., Kjos, $.L., Biuhling, K.J., Henrich, W., Diabetes Illness Representations Questionnaire: four studies with Brauer, M., Heinze, T., Dudenhausen, J.W. & Vetter, K. adolescents, 283 Amniotic fluid insulin levels and fetal abdominal circumference at Skinner, T.C. see Parkin, T. time of amniocentesis in pregnancies with diabetes, 349 Skjzrbek, C. see Frystyk, J. Schatz, H. see Zimny, S. Skovlund, S.E. see Bott, U. Scheffer, P.G., Bos, G., Volwater, H.G.F.M., Dekker, J.M., Heine, Slattery, J. see Morris, A. R.J. & Teerlink, T. Associations of LDL size with in vitro Smidts, D. see Cameron, F.]. oxidizability and plasma levels of in vivo oxidized LDL in Type 2 Smith, K. see Dunne, F. diabetic patients, 563 Smith, K. see Owen, K.R. Schmekal, B. see Biesenbach, G. Smith, $.M., Holohan,J. ,M cAuliffe, A. & Firth, R.G. Irish diabetes Schmidt, K. & Ernst, E. Complementary/alternative medicine for detection programme in general practice, 717 diabetes. How good is advice offered on websites? 248 Smith, $.M., O’Leary, M., Bury, G., Shannon, W., Tynan, A., Schnedl, W.J. see Lahousen, T. Staines, A. & Thompson, C. A qualitative investigation of the Schnell, O. see Hattori, N views and health beliefs of patients with Type 2 diabetes following Schramm, W., Bergrem, H., Cromme, P., Feest, T., Borch-Johnsen, the introduction of a diabetes shared care service, 853 K., Feldt-Rasmussen, B. & Landgraf, R. First referral of diabetic Smith, V. see Channon, S. patients to a nephrologist, 689 Smith-Laitton, E. see Treml, H. Schroeder, M. see Kaila, B. Smyth, C. see Bain, S.C. Schvarcz, E. see Ingberg, C-M. Snehalatha, C. see Ramachandran, A. Schwaiger, M. see Hattori, N. Snoek, F.J. see Adriaanse, M.C. Scioscia, M. see Greco, P. So, W.-Y. see Ko, G.T.C. Scott, A.R. see Dhindsa, P. Sommerfield, A.J., Ewing, F.M.E., Strachan, M.W.J., Deary, L.J., Scott, R.S. see Florkowski, C.M. Aitken, G. & Frier, B.M. Self-treatment of mild symptomatic Scuffham, P. & Carr, L. The cost-effectiveness of continuous hypoglycaemia by people with insulin-treated diabetes, 686 subcutaneous insulin infusion compared with multiple daily de Sonnaville, J.J.J. see Renders, C.M. injections for the management of diabetes, 586 Song, Y.D. see Kim, D.]. Selvaggi, L. see Greco, P. Sonksen, P.H. see Holt, R.I.G. Semetkowska-Jurkiewicz, B. see Rachon, D. Soorani-Lunsing, R.J. see Willemsen, M.A.A.P. Senthilvelmurugan, M. see Velmurugan, K. Soper, C. see Zhao, H.X. Shah, A.M. see Wheatcroft, S.B. Sorensen, B. see Jensen, D.M. Shannon, W. see Smith, $.M. Spijkerman, A.M.W. see Adriaanse, M.C. Sharp, P.F. see Olson, J.A. Spruce, M.C., Potter, J. & Coppini, D.V. The pathogenesis and Sharp, P.S., Rainbow, S. & Mukherjee, S. Serum levels of low management of painful diabetic neuropathy: a review, 88 molecular weight advanced glycation end products in diabetic Staehr, P., Hojlund, K., Hother-Nielsen, O., Holst, J.J. & subjects, 575 Beck-Nielsen, H. Does overnight normalization of plasma glucose Shaw, J. see Zimmet, P. by insulin infusion affect assessment of glucose metabolism in Shaw, J.E. see Tapp, R.J. Type 2 diabetes?, 816 Shaw, J.E. see Williams, J.W. Staines, A. see Smith, $.M. Shiell, A.W. see Newsome, C.A. Standl, E. see Hattori, N. Shier, R. see Newsome, C.A. Stavrou, P. see Basu, A. Shin, D.H. see Choi, K.M. Steel, J.M. St Vincent’s Declaration 10 years on: outcome of diabetic Shin, J. see McFarlane, S.I. pregnancies, 82 Shore, A.C. see Konopatskaya, O. Stenhouse, E. see Zhao, H.X. Siebenhofer, A., Ng, L.L., Plank, J., Berghold, A., Hodl, R. & Stephenson, C.R. see Feltbower, R.G. Pieber, T.R. Plasma N-terminal pro-brain natriuretic peptide in Stolk, R.P. see Goudswaard, A.N. Type 1 diabetic patients with and without diabetic nephropathy, Strachan, M.W.J., Gough, K., McKnight, J.A. & Padfield, P.L. 5 35 Reply, 509 Signorile, A. see Bo, S. Strachan, F.M. see Olson, J.A. Simonson, G.D. see Mazze, R.S. Strachan, M.W.J. see Sommerfield, A.J. Simpson, H.L. see Holt, R.I.G. Strachan, M.W.]., Frier, B.M. & Deary, I.J. Type 2 diabetes and Singh,D.L. & Bhattarai, M.D. High prevalence of diabetes and cognitive impairment, 1 impaired fasting glycaemia in urban Nepal, 170 Sturrock, N.D.C. see Amin, P. © 2003 Diabetes UK. Diabetic Medicine, 20, 1041-1055

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.